A detailed history of Key F Inancial Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Key F Inancial Inc holds 9 shares of BMRN stock, worth $599. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9
Previous 9 -0.0%
Holding current value
$599
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021

SELL
$74.77 - $85.47 $6,804 - $7,777
-91 Reduced 91.0%
9 $1,000
Q4 2020

Jan 29, 2021

BUY
$72.61 - $90.2 $7,261 - $9,020
100 New
100 $9,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.